Tatva Chintan Pharma will be open Date 16 July 2021 and close to 20 July 2021. Tatva Chintan Pharma IPO GMP Kostak rate and Subject to Sauda updated as of Today. Tatva Chintan IPO Grey Market Premium has been with high Premium Rates, We need to wait for the rates to change with the Market Sentiment in a few days or to Stabilize the Rates.
Tatva Chintan Company is one of the leading global producers of an entire range of PTCs in India and one of the key producers across the globe. As a manufacturer of specialty chemicals, we focus on the application of our products which form a key ingredient to our customers’ manufacturing and industrial processes. For instance, our SDA and PTC products have various applications in green chemistry, which is pertinent considering the growing focus on green and sustainable technologies.
Tatva Chintan Pharma IPO Issue size of ₹500 Crores, in which Fresh Issue of ₹225 Crores and Offer For Sale of ₹275 Crores and issue price band has been fixed at ₹1073-₹1083 Per Share. The Tatva Chintan Pharma IPO is to be listed Soon on NSE and BSE.
What is Tatva Chintan Pharma IPO GMP Today?
■ The Tatva Chintan Pharma IPO GMP Today Or Grey Market Premium is ₹1130-₹1140.
What is Tatva Chintan Pharma IPO Kostak Rates Today?
■ The Tatva Chintan Pharma IPO Kostak rate is ₹550.
What is Tatva Chintan Pharma IPO Subject to Sauda Price Today?
■ The Tatva Chintan Pharma IPO Subject to Sauda rates is ₹10500.
Tatva Chintan Pharma IPO Approximately Returns?
■ The Tatva Chintan Pharma IPO’s approximate return is 90%-100%. And it can also change according to the Market Sentiment.
Tatva Chintan Pharma IPO GMP, Kostak,& Subject to Sauda :
| Date | GMP | Kostak | Subject |
| 29 July 2021 | List – 2111.85 | ₹550 | ₹10500 |
| 28 July 2021 | ₹1140-₹1150 | ₹550 | ₹10500 |
| 27 July 2021 | ₹1130-₹1140 | ₹550 | ₹10500 |
| 26 July 2021 | ₹1120-₹1140 | ₹550 | ₹10500 |
| 25 July 2021 | ₹1040-₹1050 | ₹550 | ₹10500 |
| 24 July 2021 | ₹1015-₹1025 | ₹550 | ₹8500 |
| 23 July 2021 | ₹1010-₹1020 | ₹500 | ₹8500 |
| 22 July 2021 | ₹960-₹980 | ₹450 | ₹8000 |
| 21 July 2021 | ₹900-₹910 | ₹450 | ₹7500 |
| 20 July 2021 | ₹760-₹770 | ₹450 | ₹7300 |
| 19 July 2021 | ₹760-₹770 | ₹450 | ₹7300 |
| 18 July 2021 | ₹685-₹695 | ₹400 | ₹7000 |
| 17 July 2021 | ₹685-₹695 | ₹400 | ₹7000 |
| 16 July 2021 | ₹590-₹600 | ₹400 | ₹6500 |
| 15 July 2021 | ₹590-₹600 | ₹400 | ₹5500 |
| 14 July 2021 | ₹590-₹600 | ₹350 | ₹5000 |
| 13 July 2021 | ₹500-₹510 | ₹300 | ₹5000 |
| 12 July 2021 | ₹550-₹560 | ₹300 | ₹5000 |
Tatva Chintan Pharma IPO Date & Price Band & Details :
| IPO Open : | 16 July 2021 |
| IPO Close : | 20 July 2021 |
| IPO Size : | ₹500. Cr |
| Face Value : | ₹10 Rs. Equity Share |
| Price Band : | ₹1073-₹1083 Per Share |
| Listing On : | BSE, NSE |
| Issue Size : | ₹500. Cr |
| Fresh Issue : | ₹225. Cr |
| Offer For Sale : | ₹275. Cr |
Tatva Chintan Pharma IPO Market Lot :
Tatva Chintan Pharma IPO Minimum Market lot is 1 Lot with 13 shares with ₹14,079 Application amount. The retail investors can apply up to 14 lots with 182 Shares or ₹197,106 amounts.
| Minimum Lot Size : | 1 Lot |
| Minimum Share : | 13 |
| Minimum Amount : | ₹14,079 |
| Maximum Lot Size : | 14 |
| Maximum shares : | 182 |
| Maximum Amount : | ₹197,106 |
Tatva Chintan Pharma IPO Shares Offer :
A total of 4616805 shares are to be bid for the public issue by Tatva Chintan Pharma IPO with 2077562 for Fresh issue and 2539243 for an offer for sale Shares.
| Category | Shares Offers | Amount |
|---|---|---|
| Fresh issue : | 2077562 | ₹225 Cr |
| Offer For Sale : | 2539243 | ₹275 Cr |
| Total : | 4616805 | ₹500 Cr |
Tatva Chintan Pharma IPO Reservation :
Tatva Chintan Pharma IPO Total Reservation of 4616805 shares are to be bid for the public issue by Tatva Chintan Pharma IPO with 2308403 for QIB and 692520 for NII 1615882 For RII & – Shares EMP.
| Category | Reservation | Shares | Amount |
|---|---|---|---|
| QIB : | 50% | 2308403 | ₹250 Cr |
| NII : | 15% | 692520 | ₹75 Cr |
| RII : | 35% | 1615882 | ₹175 Cr |
| EMP : | – % | – | ₹ |
| Total : | 100% | 4616805 | ₹500 Cr |
Tatva Chintan Pharma IPO Dates :
Tatva Chintan Pharma IPO Date is 16 July 2021 and closes 20 July 2021. The allotment will be finalized on 26 July 2021 and the IPO may list on 29 July 2021.
| Open Date : | 16 July 2021 |
| Close Date : | 20 July 2021 |
| Allotment Date : | 26 July 2021 |
| Refund Date : | 27 July 2021 |
| Share Credit Date : | 28 July 2021 |
| Listing Date : | 29 July 2021 |
Tatva Chintan Pharma Company Financial Report (Cr) :
| Year | Revenue | Expense | PAT |
| 2020 | ₹2,646.22 | ₹2,170.25 | ₹377.89 |
| 2019 | ₹2,068.01 | ₹1,801.57 | ₹205.43 |
| 2018 | ₹1,372.88 | ₹1,182.54 | ₹122.89 |
About Tatva Chintan Pharma Company
Tatva Chintan Pharma is a chemical company based in Gujarat. The company will use the proceeds from the sale of the fresh issue shares for expansion of the production facility, up-gradation of the R&D unit at Vadodara, and for general company requirements. Tatva Chintan Company is one of the leading global producers of an entire range of PTCs in India and one of the key producers across the globe. As a manufacturer of specialty chemicals, we focus on the application of our products which form a key ingredient to our customers’ manufacturing and industrial processes. For instance, our SDA and PTC products have various applications in green chemistry, which is pertinent considering the growing focus on green and sustainable technologies.
We are a specialty chemicals manufacturing company engaged in the manufacture of a diverse portfolio of structure-directing agents (“SDAs”), phase transfer catalysts (“PTCs”), electrolyte salts for supercapacitor batteries and pharmaceutical and agrochemical intermediates, and other specialty chemicals (“PASC”). Our Company is the largest and only commercial manufacturer of SDAs for zeolites in India. It also enjoys the second-largest position globally. (Source: F&S Report) In addition, our Company is one of the leading global producers of an entire range of PTCs in India and one of the key producers across the globe. (Source: F&S Report)
As a manufacturer of specialty chemicals, we focus on the application of our products which form a key ingredient to our customers’ manufacturing and industrial processes. For instance, our SDA and PTC products have various applications in green chemistry, which is pertinent considering the growing focus on green and sustainable technologies. For further details, see “ – Our Products and Operations” on page 152. We continuously strive to improve our processes and infrastructure to help reduce our impact on the environment and have accordingly, undertaken various ‘green’ chemistry processes such as electrolysis. Considering the wide application of our products.
| Read also: All Upcoming IPO Grey Market Premium 2021 |
we serve customers across various industries, including the automotive, petroleum, pharmaceutical, agrochemicals, paints and coatings, dyes and pigments, personal care, and flavor and fragrances industries. Apart from our customers in India, we also export our products to over 25 countries, including the USA, China, Germany, Japan, South Africa, and the UK. During the Fiscals ended March 31, 2018, 2019, and 2020, and in the nine months ended December 31, 2020, exports of products accounted for 64.99%, 69.57%, 76.74%, and 70.72%, of our revenue from operations, respectively.
Tatva Chintan Pharma IPO GMP FAQs :
How much is Tatva Chintan Pharma IPO GMP Today?
Tatva Chintan Pharma IPO GMP Today is ₹1130-₹1140.
How much is Tatva Chintan Pharma IPO Grey Market Premium?
Tatva Chintan Pharma IPO is Grey Market Premium ₹1130-₹1140.
What is Tatva Chintan Pharma IPO Kostak Rate?
Tatva Chintan Pharma IPO Kostak Rate is ₹550.
What is Tatva Chintan Pharma IPO Subject to Sauda?
Tatva Chintan Pharma IPO Subject to Deals is ₹10500.
What is Tatva Chintan Pharma IPO Approx Returns?
Tatva Chintan Pharma IPO approx Returns is 80%-90%. And it can also change according to the Market Sentiment.
| Tatva Chintan Pharma IPO Details: Click Here Tatva Chintan Pharma IPO Subscription: Click Here Tatva Chintan Pharma IPO Allotment: Click Here Tatva Chintan Pharma IPO Listing: Click Here |
All Tatva Chintan Pharma IPO-related links are available here. If you want to know the details then click on Click Here Link.
Disclaimer: STOCK MARKET INVESTMENTS ARE SUBJECT TO MARKET RISKS, READ ALL SCHEME RELATED DOCUMENTS CAREFULLY.